Plasma Rich in Growth Factors in Macular Hole Surgery

5Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study was to evaluate the use of PRGF (plasma rich in growth factors) as an adjuvant to PPV (pars plana vitrectomy) in recurrent, persistent, or poor prognosis MH (macular hole). Patients with MH were treated with PPV plus adjuvant therapy (PRGF membrane (mPRGF) and injectable liquid PRGF (iPRGF)). The anatomical closure of MH and postoperative BCVA (best-corrected visual acuity) were evaluated. Eight eyes (eight patients) were evaluated: myopic MH (MMH, n = 4), idiopathic MH (IMH, n = 2), iatrogenic n = 1, traumatic n = 1. The mean age was 53.1 ± 19.3 years. Hence, 66.7% (n = 4) of patients previously had internal limiting membrane peeling. Five patients (62.5%) received mPRGF and iPRGF, and three patients (37.5%) received iPRGF. Gas tamponade (C3F8) was placed in seven cases and one case of silicone oil. Anatomic closure of MH was achieved in seven eyes (87.5%) and BCVA improved in six cases. In the MMH group, visual acuity improved in two lines of vision. Follow-up time was 27.2 ± 9.0 months. No adverse events or MH recurrences were recorded during follow-up. The use of PRGF as an adjuvant therapy to PPV can be useful to improve anatomical closure and visual acuity in MH surgery.

References Powered by Scopus

The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole

966Citations
N/AReaders
Get full text

Macular hole size as a prognostic factor in macular hole surgery

340Citations
N/AReaders
Get full text

Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography

307Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Platelet concentrates in macular hole surgery. A journey through the labyrinth of terminology, preparation, and application: a comprehensive review

3Citations
N/AReaders
Get full text

Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy

1Citations
N/AReaders
Get full text

Successful use of PRGF-endoret® and ILM peeling for full thickness macular hole in MacTel type 2: A case report and review of literature

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sánchez-ávila, R. M., Robayo-Esper, C. A., Villota-Deleu, E., Sanz, Á. F. V., González, Á. F. V., de la Sen-Corcuera, B., … Merayo-Lloves, J. (2022). Plasma Rich in Growth Factors in Macular Hole Surgery. Clinics and Practice, 12(1), 57–69. https://doi.org/10.3390/clinpract12010007

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Professor / Associate Prof. 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

80%

Biochemistry, Genetics and Molecular Bi... 1

20%

Save time finding and organizing research with Mendeley

Sign up for free